Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation

Chest. 2003 Dec;124(6):2239-43. doi: 10.1378/chest.124.6.2239.

Abstract

Objective: To determine the epidemiology of pneumonia in patients with tracheotomy receiving short-term mechanical ventilation.

Design: Observational prospective study.

Setting: A 14-bed medical-surgical ICU.

Subjects: Ninety-nine critically ill acute patients requiring percutaneous dilatational tracheotomy for mechanical ventilation.

Interventions: Tracheal aspirate obtained 48 h before tracheotomy.

Measurements and main results: Eighteen patients (18.1%) acquired pneumonia (median of 7 days after tracheotomy). Pseudomonas aeruginosa was the most frequently identified pathogen, found in eight of the episodes (four not documented by prior tracheal colonization), followed by other Gram-negative bacilli. The development of ventilator-associated pneumonia (VAP) was not anticipated by any clinical variable. A positive tracheal aspirate (TA) culture result obtained before tracheotomy was associated with a risk of acquiring pneumonia of 19.7%, whereas sterile TA cultures were associated with a risk of 14.3% (p > 0.20). VAP prolonged ICU stay or the ventilation period for a median of 19 days and 15 days, respectively. Overall mortality was 34.3%, but the presence of VAP did not increase the mortality rate.

Conclusions: Percutaneous tracheotomy in patients receiving short-term mechanical ventilation predisposes to pneumonia. Pneumonia was associated with prolonged ventilation and ICU stay, but was not associated with increased mortality. Pseudomonas is a common pathogen after tracheotomy, and this observation should be considered in selecting an antibiotic regimen, because TA obtained prior to the tracheotomy often failed to identify this pathogen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • APACHE
  • Critical Care*
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Cross Infection / therapy
  • Female
  • Hospital Mortality
  • Humans
  • Incidence
  • Intensive Care Units
  • Male
  • Middle Aged
  • Pneumonia / epidemiology*
  • Pneumonia / microbiology
  • Pneumonia / therapy
  • Prospective Studies
  • Pseudomonas aeruginosa / isolation & purification*
  • Pseudomonas aeruginosa / pathogenicity
  • Respiration, Artificial / adverse effects*
  • Tracheotomy